Financial Performance
5Y price score: 45
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 48.1%
US$ Per
Share
By default your notes are visible only to you.
54.7
52-week range
77.0
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
7.6 %
Dividend Yield TTM
6.5 %
Market cap $
$ 108,667
Price / Earnings TTM
13.7
Price / Book TTM
(40.8)
PEG TTM
(0.4)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
5.7 %
73.4 %
48.1 %
Free cash flow per share growth
8 %
23.4 %
90.3 %
Earnings per share growth
(37.2) %
71.3 %
53.9 %
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Jul 30, 2026)
1) Strategy & Leadership - Altria's CEO, Sal Mancuso, emphasized the company's commitment to advancing its smoke-free portfolio while strengthening traditional tobacco businesses. - The company returned nearly $3.9 billion to shareholders through dividends and share repurchases in the first half of 2026. - The launch of Marlboro Cowboy Cut aims to engage value-sensitive consumers while celebrating America's 250th anniversary. - Altria is focused on maintaining a balance between premium and discount segments to maximize long-term profitability.
2) Financial & Segment Results - Adjusted diluted EPS increased by 2.8% to $1.48 in Q2 and by 4.9% to $2.80 for the first half. - Adjusted OCI for smokeable products grew by 2.4% to $3 billion in Q2, with margins expanding to 64.8%. - Domestic cigarette volumes declined 3.2% in Q2 and 2.8% in the first half, with industry volumes down 5%. - The Oral Tobacco Products segment saw an 8.5% decline in shipment volume in Q2, impacted by prior year comparisons and strategic investments in on! PLUS.
3) Problems / Headwinds - Economic pressures, including high gas prices and inflation, continue to impact adult smokers' purchasing behavior. - The discount segment's growth is primarily driven by consumers trading down due to financial constraints. - The nicotine pouch category is facing intensified competition, requiring strategic investments to maintain market share.
4) Operational or Product Plans - Helix's on! PLUS expanded to 120,000 stores, with shipment volume down 4.2% in Q2 due to inventory movements but up 5.1% year-to-date. - The FDA's updated enforcement priorities provide regulatory clarity for future product launches, including flavor extensions for on! PLUS. - Altria plans to introduce new flavors and higher strength options for on! PLUS in Q4 2026.
5) Guidance & Outlook / Investor Angle - Altria raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.61 to $5.72, reflecting a growth rate of 3.5% to 5.5%. - The company remains cautious about consumer health and purchasing behaviors, particularly in the context of ongoing economic pressures. - Altria's strong balance sheet and cash generation position it well for managing upcoming debt maturities and continuing shareholder returns.
Bottom line: Altria's solid first half performance, strategic investments in its smoke-free portfolio, and a favorable regulatory environment position the company for continued growth, despite economic headwinds and competitive pressures. Shareholders can expect stable returns as the company navigates these challenges while expanding its product offerings.
Annual Reports, Presentations And IR Contacts
Go to the websiteAltria Group, Inc. — Financial Overview, Stock Price, Market Cap
Altria Group, Inc. is a company. Founded in 1985. As of August 14, 2026, the company's market capitalization is $108666936982 with a current stock price of $65.08.
